Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › WI › West Allis › NPI 1710064811
Lab

A2cl Services, LLC

A2cl Services, LLC was paid $98.74M by Medicaid between Jan 2018 and Dec 2024, across 432 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 8.6% of everything it billed.

33Billing provider infoA2CL SERVICES, LLC
WEST ALLIS, WI 53227
33aNPI1710064811assigned 11/01/2006
33bProvider typeClinical Medical Laboratory
28Total paid$98.74M
24GClaims5,951,837
24DCodes billed432
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Medical Laboratory providers in Wisconsin

Rank by total paid#2 of 75
Median peer was paid$106K
This provider vs. median928×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official RICHARDSON, KARA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M$3.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018704,807$11.71M
2019678,214$10.20M
2020627,379$10.06M
2021836,058$15.85M
2022767,246$13.58M
2023973,588$15.28M
2024incomplete1,364,545$22.06M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 8.6% 112,923 101,174 $8.46M
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 6.4% 179,197 167,500 $6.28M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 6.3% 178,828 167,034 $6.22M
84443 Thyroid stimulating hormone (TSH) 3.3% 236,679 221,566 $3.30M
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 3.3% 102,307 95,399 $3.29M
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 3.2% 107,395 99,410 $3.16M
80053 Comprehensive metabolic panel 3.2% 343,050 313,254 $3.12M
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 3.1% 152,005 144,405 $3.07M
80050 General health panel 3.1% 70,941 64,439 $3.03M
80061 Lipid panel 3.0% 306,766 289,177 $2.95M
81513 2.7% 32,468 30,425 $2.70M
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 2.5% 110,615 104,731 $2.42M
420 more codes
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 2.4% 78,370 $2.32M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.9% 301,317 $1.86M
83036 Hemoglobin; glycosylated (A1C) 1.9% 254,934 $1.84M
87481 1.8% 33,341 $1.82M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.5% 92,683 $1.45M
86480 1.5% 26,084 $1.43M
87086 Culture, bacterial; quantitative colony count, urine 1.3% 171,444 $1.29M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.3% 18,334 $1.28M
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 1.3% 30,366 $1.25M
88305 Level IV - Surgical pathology, gross and microscopic examination 1.2% 37,490 $1.22M
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 26,925 $1.21M
87507 <1% 3,407 $934K
86803 <1% 65,497 $862K
82607 <1% 63,007 $784K
80048 Basic metabolic panel (calcium, ionized) <1% 94,521 $670K
86235 <1% 7,065 $634K
83970 <1% 20,153 $619K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,956 $617K
82728 <1% 58,609 $598K
87529 <1% 9,859 $584K
84439 <1% 69,906 $545K
87340 <1% 51,909 $519K
82746 <1% 42,996 $518K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 9,478 $512K
87563 <1% 20,125 $505K
86003 <1% 11,381 $504K
80081 <1% 8,500 $501K
83655 <1% 41,235 $485K
85027 <1% 82,892 $482K
84153 <1% 32,052 $473K
87186 <1% 52,144 $467K
87081 <1% 72,285 $464K
84702 <1% 37,428 $445K
83550 <1% 59,396 $433K
86780 <1% 37,268 $417K
83880 <1% 15,080 $411K
84403 <1% 15,713 $354K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 11,379 $353K
82570 <1% 83,678 $352K
0240U <1% 5,730 $347K
83540 <1% 63,201 $343K
82043 <1% 75,430 $341K
80074 <1% 10,790 $330K
86762 <1% 27,471 $329K
87077 <1% 40,286 $299K
81420 Fetal chromosomal aneuploidy genomic sequence analysis panel <1% 573 $291K
84481 <1% 22,176 $280K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 7,551 $268K
86592 <1% 67,013 $267K
87088 <1% 34,215 $259K
86706 <1% 25,711 $259K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed <1% 1,735 $255K
87902 <1% 1,115 $254K
86787 <1% 25,567 $243K
82784 <1% 18,544 $241K
86140 <1% 50,943 $231K
86038 <1% 20,388 $229K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 2,012 $224K
81001 <1% 82,062 $223K
84146 <1% 13,560 $222K
82105 <1% 14,246 $217K
83001 <1% 13,175 $217K
83735 <1% 37,633 $215K
86704 <1% 17,807 $196K
87522 Neg quan hep c or qual rna <1% 4,840 $191K
87480 <1% 9,853 $189K
87510 <1% 9,848 $184K
82670 <1% 8,816 $182K
83516 <1% 11,618 $180K
87070 <1% 23,870 $180K
87536 <1% 2,405 $179K
87660 <1% 9,785 $173K
80076 <1% 23,619 $168K
87641 <1% 6,411 $167K
86850 <1% 30,061 $166K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 4,140 $146K
88341 <1% 2,207 $143K
85610 <1% 40,736 $139K
82274 <1% 11,812 $138K
87808 <1% 10,824 $138K
87493 <1% 4,583 $136K
83013 <1% 3,383 $132K
82950 <1% 26,039 $120K
88342 <1% 6,031 $118K
86665 <1% 4,162 $116K
86160 <1% 6,862 $116K
83002 <1% 8,490 $116K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 903 $114K
83690 <1% 17,812 $111K
86200 <1% 9,633 $108K
87521 Neg quan hep c or qual rna <1% 3,384 $108K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 687 $107K
84144 <1% 6,175 $106K
86696 <1% 5,515 $104K
87640 <1% 5,323 $104K
83020 <1% 11,590 $103K
85652 <1% 42,026 $101K
81329 <1% 1,265 $101K
86376 <1% 8,445 $100K
84270 <1% 5,468 $99K
87210 <1% 20,840 $99K
86364 <1% 8,261 $97K
87505 <1% 1,200 $97K
82533 <1% 6,873 $95K
86618 <1% 6,174 $95K
88307 <1% 1,489 $94K
88344 <1% 1,025 $92K
86146 <1% 2,489 $91K
88304 <1% 6,292 $90K
88142 <1% 6,213 $89K
86147 <1% 3,268 $88K
87517 <1% 2,142 $86K
84484 <1% 7,289 $85K
84156 <1% 29,058 $85K
86800 <1% 6,304 $85K
84550 <1% 22,332 $83K
87205 <1% 20,970 $82K
88312 <1% 3,884 $82K
86901 <1% 25,875 $81K
84425 <1% 4,726 $80K
86431 <1% 14,922 $79K
83520 <1% 5,562 $79K
80197 <1% 7,181 $76K
83721 <1% 10,423 $75K
86225 <1% 6,567 $75K
83525 <1% 7,322 $72K
82951 <1% 5,859 $72K
84165 <1% 7,448 $72K
81003 <1% 35,083 $71K
86900 <1% 24,848 $70K
86334 <1% 3,716 $69K
82330 <1% 5,829 $68K
88112 <1% 1,991 $67K
82627 <1% 4,003 $66K
82677 <1% 3,229 $64K
84445 <1% 2,080 $63K
82565 <1% 14,385 $63K
86769 <1% 1,768 $60K
86336 <1% 3,442 $60K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 772 $60K
82024 <1% 2,050 $59K
80164 <1% 5,336 $59K
86695 <1% 4,480 $59K
83521 <1% 2,497 $58K
82550 <1% 10,571 $58K
84100 <1% 15,771 $58K
87449 <1% 5,031 $55K
84402 <1% 2,600 $55K
87075 <1% 6,287 $54K
86039 <1% 5,534 $53K
84460 <1% 11,046 $51K
83498 <1% 2,507 $50K
81374 <1% 1,116 $50K
87147 <1% 9,272 $50K
87427 <1% 4,731 $50K
83993 <1% 3,517 $49K
88173 <1% 1,342 $49K
83615 <1% 9,523 $49K
84703 <1% 6,889 $48K
87040 <1% 3,034 $48K
85379 <1% 5,406 $47K
82785 <1% 3,796 $47K
87497 <1% 1,305 $46K
82652 <1% 2,011 $45K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 1,491 $45K
80177 <1% 4,018 $44K
85730 <1% 8,836 $43K
82088 <1% 1,204 $42K
87799 <1% 1,275 $42K
87045 <1% 4,621 $42K
81025 <1% 5,541 $40K
84450 <1% 8,609 $40K
84207 <1% 1,743 $39K
82378 <1% 2,851 $38K
84630 <1% 3,771 $37K
87338 <1% 2,532 $36K
88360 <1% 506 $36K
86304 <1% 2,231 $36K
88185 <1% 400 $35K
80069 <1% 5,312 $35K
84480 <1% 3,185 $34K
85018 <1% 15,002 $34K
82247 <1% 7,249 $33K
87209 <1% 2,115 $33K
86735 <1% 2,685 $33K
82248 <1% 7,697 $33K
83921 <1% 1,963 $32K
G0416 Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method <1% 128 $31K
86341 <1% 1,298 $31K
85390 <1% 3,306 $31K
85613 <1% 3,328 $31K
86765 <1% 2,947 $30K
82140 <1% 2,516 $30K
88262 <1% 272 $30K
86870 <1% 828 $30K
86361 <1% 1,333 $28K
86708 <1% 2,810 $28K
80055 <1% 1,625 $28K
82977 <1% 4,949 $28K
82150 <1% 4,603 $27K
84305 <1% 1,616 $27K
82947 <1% 7,688 $27K
G0103 Prostate cancer screening; prostate specific antigen test (psa) <1% 3,025 $27K
84166 <1% 1,724 $25K
86300 <1% 1,085 $25K
87625 <1% 914 $25K
84244 <1% 1,320 $25K
80175 <1% 2,228 $24K
86258 <1% 1,636 $24K
82390 <1% 2,568 $24K
86381 <1% 1,482 $23K
86255 <1% 1,067 $23K
82103 <1% 2,085 $23K
83630 <1% 1,804 $22K
85046 <1% 4,660 $22K
82239 <1% 1,462 $22K
84145 <1% 966 $22K
80178 <1% 3,918 $22K
82077 <1% 1,719 $21K
86141 <1% 1,752 $21K
86705 <1% 1,892 $20K
99000 <1% 6,681 $20K
85014 <1% 9,311 $20K
82952 <1% 5,311 $20K
84202 <1% 1,364 $20K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 794 $19K
86677 <1% 2,351 $19K
86644 <1% 1,421 $19K
84681 <1% 1,905 $19K
87046 <1% 4,727 $18K
85732 <1% 3,292 $18K
82657 <1% 999 $18K
81229 <1% 95 $18K
87177 <1% 2,163 $17K
83883 <1% 938 $17K
85245 <1% 1,028 $16K
87102 <1% 2,360 $16K
84432 <1% 1,185 $16K
86617 <1% 683 $16K
84134 <1% 2,093 $15K
83835 <1% 1,069 $15K
84132 <1% 3,800 $15K
86015 <1% 1,592 $15K
83090 <1% 1,068 $14K
80047 <1% 1,604 $14K
86301 <1% 918 $14K
86709 <1% 1,641 $14K
86008 <1% 228 $14K
88230 <1% 210 $14K
80143 <1% 964 $13K
82164 <1% 1,060 $13K
84155 <1% 4,467 $13K
80179 <1% 919 $12K
82610 <1% 1,005 $12K
86694 <1% 893 $12K
82525 <1% 1,146 $12K
88237 <1% 161 $12K
88184 <1% 420 $11K
83605 <1% 1,117 $11K
84080 <1% 993 $11K
82653 <1% 611 $11K
81240 <1% 337 $10K
86849 <1% 214 $10K
88275 <1% 201 $10K
82803 <1% 427 $10K
86645 <1% 934 $10K
82397 <1% 776 $10K
84466 <1% 1,052 $10K
85576 <1% 329 $10K
87800 <1% 469 $9K
87076 <1% 1,192 $9K
84478 <1% 1,980 $9K
86308 <1% 1,963 $9K
80156 <1% 753 $9K
84436 <1% 1,514 $9K
88271 <1% 196 $9K
86593 <1% 2,298 $9K
84520 <1% 2,434 $8K
81401 <1% 270 $8K
85246 <1% 538 $8K
83010 <1% 782 $8K
82040 <1% 2,096 $8K
84163 <1% 616 $7K
80299 <1% 270 $7K
85049 <1% 1,840 $7K
82310 <1% 1,688 $7K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 482 $7K
89051 <1% 1,422 $7K
84075 <1% 1,604 $7K
82465 <1% 1,773 $7K
81479 Unlisted molecular pathology procedure <1% 127 $7K
82962 <1% 2,037 $7K
85240 <1% 615 $6K
82340 <1% 1,197 $6K
85660 <1% 1,214 $6K
82157 <1% 304 $6K
80183 <1% 572 $6K
81243 <1% 182 $6K
84238 <1% 200 $6K
36415 Collection of venous blood by venipuncture <1% 14,427 $6K
83519 <1% 250 $6K
80202 <1% 451 $6K
87015 <1% 1,203 $5K
86777 <1% 393 $5K
85670 <1% 3,194 $5K
80185 <1% 414 $5K
85306 <1% 366 $5K
85307 <1% 361 $4K
85598 <1% 293 $4K
82104 <1% 398 $4K
87116 <1% 461 $4K
84300 <1% 998 $4K
84590 <1% 474 $4K
82542 <1% 248 $4K
87350 <1% 389 $4K
82166 <1% 296 $4K
87150 <1% 116 $4K
83695 <1% 561 $4K
87101 <1% 490 $4K
86256 <1% 312 $4K
85303 <1% 324 $4K
86335 <1% 162 $4K
88313 <1% 167 $3K
82365 <1% 320 $3K
87106 <1% 379 $3K
85247 <1% 203 $3K
87807 <1% 255 $3K
88264 <1% 29 $3K
87206 <1% 648 $3K
G0472 Hepatitis c antibody screening, for individual at high risk and other covered indication(s) <1% 614 $3K
82668 <1% 214 $3K
83718 <1% 424 $3K
86036 <1% 321 $3K
87468 <1% 103 $3K
81206 <1% 26 $3K
87484 <1% 97 $3K
83789 <1% 136 $3K
86778 <1% 172 $2K
88302 <1% 166 $2K
81256 <1% 56 $2K
89060 <1% 313 $2K
81050 <1% 697 $2K
84182 <1% 28 $2K
82731 <1% 29 $2K
82085 <1% 257 $2K
86060 <1% 261 $2K
86707 <1% 196 $2K
80235 <1% 122 $2K
84446 <1% 190 $2K
86162 <1% 115 $2K
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed <1% 15 $2K
82747 <1% 120 $2K
86832 <1% 14 $2K
87593 <1% 44 $1K
82787 <1% 100 $1K
86360 <1% 40 $1K
81015 <1% 553 $1K
84154 <1% 76 $1K
86833 <1% 13 $1K
82232 <1% 110 $1K
83935 <1% 238 $1K
87176 <1% 260 $1K
87109 <1% 84 $1K
87181 <1% 103 $1K
82261 <1% 66 $1K
87324 <1% 98 $906.37
88300 <1% 78 $813.38
86337 <1% 53 $799.17
83014 <1% 87 $776.71
82530 <1% 56 $744.64
G0475 Hiv antigen/antibody, combination assay, screening <1% 193 $715.65
G0143 Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision <1% 87 $713.05
99001 <1% 155 $708.31
88333 <1% 39 $704.36
85300 <1% 66 $703.39
86359 <1% 26 $690.86
88311 <1% 347 $689.44
87469 <1% 28 $687.74
82985 <1% 51 $687.19
86682 <1% 54 $635.62
81270 <1% 14 $616.27
85048 <1% 310 $614.22
84133 <1% 162 $584.51
84482 <1% 59 $583.95
87999 <1% 14 $575.51
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge <1% 865 $554.79
84295 <1% 111 $486.72
86077 <1% 18 $471.02
83930 <1% 87 $433.06
84597 <1% 42 $414.27
87107 <1% 41 $320.42
82955 <1% 39 $292.17
84255 <1% 13 $269.76
87425 <1% 18 $266.40
86041 <1% 26 $246.74
82626 <1% 13 $214.13
82017 <1% 12 $167.02
87385 <1% 13 $144.03
80051 <1% 18 $135.31
80184 <1% 13 $129.82
87341 <1% 15 $125.81
82575 <1% 15 $125.45
86666 <1% 15 $113.47
82172 <1% 12 $112.28
82180 <1% 12 $105.82
84560 <1% 26 $105.00
86753 <1% 15 $99.95
80201 <1% 14 $99.23
80203 <1% 12 $90.10
86886 <1% 15 $87.81
87207 <1% 12 $76.68
80321 <1% 227 $76.00
84479 <1% 13 $72.97
84105 <1% 12 $56.65
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled <1% 133 $52.08
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 62 $12.92
36416 <1% 12 $6.11
80325 0% 29 $0.00
80348 0% 294 $0.00
80349 0% 33 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRICHARDSON, KARA (ASSISTANT TREASURER)
Same official

Other billing entities under RICHARDSON, KARA

Full network →
ProviderLocationPaid
Aurora Health Care Metro, INC.Milwaukee, WI$182.03M
Aurora Psychiatric Hospital, INC.Wauwatosa, WI$28.09M
Baycare Aurora, LLCGreen Bay, WI$25.37M
West Allis Memorial Hospital, INC.West Allis, WI$23.29M
Aurora Medical Center of Oshkosh, INCOshkosh, WI$16.47M
Visiting Nurse Association of Wisconsin, INC.West Allis, WI$15.36M
Aurora Health Care Central, INC.Sheboygan, WI$12.39M
Visiting Nurse Association of Wisconsin, INC.Wauwatosa, WI$9.78M
Aurora Medical Center Bay Area, INCMarinette, WI$9.68M
Lakeshore Medical Clinic, LLCSaint Francis, WI$8.38M
Ehs Home Health Care Service INCOak Brook, IL$7.28M
Aurora Health Care North, INC.Two Rivers, WI$6.80M
Advocate Home Care Products INCDowners Grove, IL$5.39M
Aurora Health Care Southern Lakes, INC.Burlington, WI$5.25M
Advocate Health and Hospitals CorporationPark Ridge, IL$3.89M
Aurora Medical Center of Washington County, INC.Hartford, WI$3.25M
Advocate Home Care Products, INCBridgeview, IL$2.37M
Advocate Health and Hospitals CorporationOak Lawn, IL$2.31M
Aurora Medical Center Bay Area, INCMarinette, WI$1.55M
Advocate North Side Health NetworkChicago, IL$1.19M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.